Dendreon (
DNDN) manufactures
PROVENGE, a ground-breaking vaccine for treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC).
The FDA decided to approve this non-traditional vaccine today, we are extremely excited for everyone affected by this incredible news. If interested in free and ongoing technical snapshots of DNDN via email after this long awaited FDA
approval, Click here.
7 comments:
Viva Viva Dendreon and potc team, Sidiq, Mumbai.
Incredibly good call again guys. Been a reader and now subscriber. Karen
$75 leap options made me very happy all day and all day tomorrow and all this year imo. Thanks for all your work.
SF bob
Your report was great, well worth the price of $30. I am thinking of joining, much better than my broker. Fred H from IL
potc potc potc, the chant continues, just a quick THANK YOU!
jb, reader and loyal subscriber of POTC blog.
you my friend are good man, all the best and I am buying 1 quarter with my profit, S. Park
best case happened today, very nice emails and work, "the chill-trader" from Jersey.
Post a Comment